Inventor
DUDKIN VADIM
US17 patents
⚠️ This page may combine multiple inventors who share the name “DUDKIN VADIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIRNA THERAPEUTICS INC
7 patentsUS9655976B2May 23, 2017
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC6 citations82
US9540639B2Jan 10, 2017
Tetragalnac containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC10 citations81
US11117917B2Sep 14, 2021
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC2 citations71
US10221205B2Mar 5, 2019
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC3 citations71
US12304925B2May 20, 2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC0 citations60
US9840531B2Dec 12, 2017
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC0 citations50
US10214742B2Feb 26, 2019
Tetragalnac containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC0 citations49
JANSSEN BIOTECH INC
5 patentsUS11576986B2Feb 14, 2023
Macrocyclic chelators and methods of use thereof
JANSSEN BIOTECH INC9 citations85
US12453785B2Oct 28, 2025
Macrocyclic chelators and methods of use thereof
JANSSEN BIOTECH INC0 citations62
US12227593B2Feb 18, 2025
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase
JANSSEN BIOTECH INC0 citations56
US12240790B2Mar 4, 2025
Radiolabeling of polypeptides
JANSSEN BIOTECH INC0 citations47
US12084475B2Sep 10, 2024
Methods for site specific conjugation of proteins containing glycosylated Fc domains
JANSSEN BIOTECH INC0 citations46